Literature DB >> 9697024

Effect of bioactive glass particle size on osseous regeneration of cancellous defects.

D L Wheeler1, K E Stokes, R G Hoellrich, D L Chamberland, S W McLoughlin.   

Abstract

The bioactive glass known as Bioglass or Perioglass (USB) (US Biomaterials, Alachua, FL) has proven to be an effective graft material owing to the apatite layer which forms on the surface of the glass, promoting bone formation. USB particles range in size from 90 to 710 microns in diameter, as determined by optical microscopy. A similar bioactive material, BioGran (OV) (Orthovita, Malvern, PA), was developed to limit the particle size of 4555 to the range between 300 and 360 microns, as determined by sieving. The objective of this study was to histologically and biomechanically compare the 4555 bioactive glass, produced by US Biomaterials, in a wide particle range (USB) to the narrower particle range glass produced by Orthovita (OV) The grafted defects will then be compared to normal cancellous bone (NORM) of the distal femur in rabbits. Histologically, more bone was quantified at both 4 and 12 weeks within the defects filled with USB and NORM when compared to the limbs filled with OV (p < 0.05). The OV particles had greater particle axes and larger particle areas on average than the USB particles (p < 0.05). However, the particle axis and area of the two materials decreased with time at a similar rate. Biomechanically, the USB- and OV-grafted defects had comparable peak compressive load, compressive stiffness, and compressive modulus which were equivalent to normal bone.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9697024     DOI: 10.1002/(sici)1097-4636(19980915)41:4<527::aid-jbm3>3.0.co;2-e

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  20 in total

1.  In vitro response of primary rat osteoblasts to titania/hydroxyapatite coatings compared with transformed human osteoblast-like cells.

Authors:  P A Ramires; F Cosentino; E Milella; P Torricelli; G Giavaresi; R Giardino
Journal:  J Mater Sci Mater Med       Date:  2002-08       Impact factor: 3.896

2.  Bioglass as a carrier for reindeer bone protein extract in the healing of rat femur defect.

Authors:  Hanna Tölli; Sauli Kujala; Katri Levonen; Timo Jämsä; Pekka Jalovaara
Journal:  J Mater Sci Mater Med       Date:  2010-02-17       Impact factor: 3.896

3.  Mechanical properties of bioactive glass (13-93) scaffolds fabricated by robotic deposition for structural bone repair.

Authors:  Xin Liu; Mohamed N Rahaman; Gregory E Hilmas; B Sonny Bal
Journal:  Acta Biomater       Date:  2013-02-21       Impact factor: 8.947

4.  Bioactive glass scaffolds for bone tissue engineering: state of the art and future perspectives.

Authors:  Qiang Fu; Eduardo Saiz; Mohamed N Rahaman; Antoni P Tomsia
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2011-10-10       Impact factor: 7.328

5.  Mouse and human islets survive and function after coating by biosilicification.

Authors:  David B Jaroch; Jing Lu; Rajtarun Madangopal; Natalie D Stull; Matthew Stensberg; Jin Shi; Jennifer L Kahn; Ruth Herrera-Perez; Michael Zeitchek; Jennifer Sturgis; J Paul Robinson; Mervin C Yoder; D Marshall Porterfield; Raghavendra G Mirmira; Jenna L Rickus
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-09-03       Impact factor: 4.310

6.  Conversion of melt-derived microfibrous borate (13-93B3) and silicate (45S5) bioactive glass in a simulated body fluid.

Authors:  Xin Liu; Mohamed N Rahaman; Delbert E Day
Journal:  J Mater Sci Mater Med       Date:  2012-12-12       Impact factor: 3.896

Review 7.  Bioactive glass in tissue engineering.

Authors:  Mohamed N Rahaman; Delbert E Day; B Sonny Bal; Qiang Fu; Steven B Jung; Lynda F Bonewald; Antoni P Tomsia
Journal:  Acta Biomater       Date:  2011-03-21       Impact factor: 8.947

Review 8.  Silicon micro- and nanofabrication for medicine.

Authors:  Daniel Fine; Alessandro Grattoni; Randy Goodall; Shyam S Bansal; Ciro Chiappini; Sharath Hosali; Anne L van de Ven; Srimeenkashi Srinivasan; Xuewu Liu; Biana Godin; Louis Brousseau; Iman K Yazdi; Joseph Fernandez-Moure; Ennio Tasciotti; Hung-Jen Wu; Ye Hu; Steve Klemm; Mauro Ferrari
Journal:  Adv Healthc Mater       Date:  2013-04-15       Impact factor: 9.933

9.  Bioactive evaluation of 45S5 bioactive glass fibres and preliminary study of human osteoblast attachment.

Authors:  Daniel C Clupper; Julie E Gough; Papy M Embanga; Ioan Notingher; Larry L Hench; Matthew M Hall
Journal:  J Mater Sci Mater Med       Date:  2004-07       Impact factor: 3.896

10.  Microparticulate cortical allograft: an alternative to autograft in the treatment of osseous defects.

Authors:  H Thomas Temple; Theodore I Malinin
Journal:  Open Orthop J       Date:  2008-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.